Therapeutic compounds
US9428494B2 · kind B2 · utility
1Cited by
0References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 2, 2007 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | Mar 31, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel compounds of formula I: that are opioid receptor ligands. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating diseases associated with opioid receptor function by administering such compounds to a mammal in need of treatment. Compounds of the invention are useful to modulate (e.g. agonize or antagonize) opioid receptor function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.